Erratum: Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients

By  

Hematological Oncology (Electronic), Vol. 33, Iss. 3, 2015-09 ,pp. : 168-168

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erratum: Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

By  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1752-1753

Blackwell Publishing

Access to resources Recommend Favorite

IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 196-201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients

By Barbee Meagan S.   Nooka Ajay   Kaufman Jonathan L.   Kim Sungjin   Chen Zhengjia   Heffner Leonard T.   Lonial Sagar   Harvey R. Donald  

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 853-862

Blackwell Publishing

Access to resources Recommend Favorite

Erratum: Reply to Letter to the Editor – Why PGD for aneuploidy should benefit reproductive outcome in poor prognosis IVF patients

By Kuliev A   Verlinsky Y  

Reproductive BioMedicine Online, Vol. 17, Iss. 4, 2008-10 ,pp. : 588-588

Reproductive Healthcare Ltd

Access to resources Recommend Favorite